Renal Artery Dopplers in Twin Twin Transfusion Syndrome
NCT03449823 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24
Last updated 2018-07-18
Summary
Twin-twin transfusion syndrome (TTTS) is a complication affecting 10-15% of monochorionic, diamniotic (MCDA) twin pregnancies. Unevenly distributed blood flow across a shared placental circulation results in a volume-restricted donor twin and a volume-overloaded recipient twin, and TTTS has high perinatal morbidity and mortality without treatment.
Differential donor and recipient findings in TTTS can be observed upon ultrasound evaluation. TTTS is classified according to the Quintero staging system, which evaluates amniotic fluid volumes, fetal bladders, Doppler study of the umbilical artery and ductus venosus, and for the presence of hydrops or death. However, due to seemingly complex and variable disease pathophysiology, the Quintero system cannot predict outcomes on a case-by-case basis.
Prior studies have associated fetal renal artery Doppler ultrasound measurements with amniotic fluid volume in singleton pregnancies. In fetuses with placental insufficiency, adaptive circulatory changes maintain adequate oxygen delivery to vital organs such as the heart, brain, and adrenals, with a consequent deprivation to splanchnic organs. In the fetal kidney, as vascular resistance increases during hypoxia, renal perfusion decreases proportionately. These changes are reflected in renal artery Doppler findings. As these same adaptations are believed to occur in donor twins, renal artery Doppler studies may also be of value in the TTTS evaluation.
This study plans to perform renal artery Doppler assessments in MCDA twins complicated by TTTS, and compare them to measurements in gestational-age equivalent MCDA twins without TTTS. If findings differ significantly, it would support further investigation into the use of renal artery Doppler studies for the evaluation of complicated MCDA twins.
Conditions
- Twin Twin Transfusion Syndrome
Interventions
- DIAGNOSTIC_TEST
-
Doppler ultrasound of fetal renal artery
Doppler ultrasound assessment of the proximal fetal renal artery to with measurement of the peak systolic velocity, resistive index, pulsatility index, and systolic/diastolic ratio.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Joses Jain, MD · Columbia University
-
Russell Miller, MD · Columbia University
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-09-09
- Primary Completion
- 2018-03-21
- Completion
- 2018-06-30
Countries
- United States
Study Locations
More Related Trials
-
Neonatal Outcome for Laser Coagulation in Twin-to-twin-transfusion Syndrome
NCT03151915 ·Status: COMPLETED
-
Topical and Intravenous Administration of TXA Are Equally Effective in DAA THA
NCT01940692 ·Status: COMPLETED ·Phase: PHASE2
-
Study Comparing Topical Versus Intravenous Tranexamic Acid in Anterior Total Hip Arthroplasty
NCT03359525 ·Status: UNKNOWN ·Phase: PHASE4
-
Tranexamic Acid for Preventing Postpartum Haemorrhage Following a Vaginal Delivery
NCT02302456 ·Status: COMPLETED ·Phase: PHASE3
-
TRANEXAMIC ACID IN PATIENTS UNDERGOING TOTAL HIP ARTHROPLASTY IN A BRAZILIAN REFERENCE ORTHOPEDIC CENTER: A RANDOMIZED CONTROLLED TRIAL
NCT03019198 ·Status: COMPLETED ·Phase: PHASE4
-
Mortality After Transfusion of Ever-pregnant Donor Red Blood Cells
NCT06176105 ·Status: COMPLETED
-
Bleeding Prevention With Desmopressin for Allograft Kidney Biopsies
NCT06622187 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Intravenous Tranexamic Acid During Rhytidectomy
NCT03970213 ·Status: UNKNOWN ·Phase: PHASE4
-
Topical (Intra-Articular) Tranexamic Acid and Transfusion Rates Following Hip Hemiarthroplasty
NCT02664909 ·Status: COMPLETED ·Phase: PHASE4
-
Prevention of Postpartum Hemorrhage With Tranexamic Acid
NCT05370820 ·Status: RECRUITING ·Phase: PHASE2
-
The Role of Tranexamic Acid in Reducing Blood Transfusion Requirements After Cardiopulmonary Bypass in Neonates
NCT01914211 ·Status: WITHDRAWN
-
Laser Photocoagulation in Twin to Twin Transfusion Syndrome
NCT02506049 ·Status: COMPLETED ·Phase: NA
-
Tranexamic Acid Dosing for Total Joint Arthroplasty
NCT02584725 ·Status: COMPLETED ·Phase: PHASE4
-
Tranexamic Acid in Pregnancies With Vaginal Bleeding
NCT03632824 ·Status: COMPLETED ·Phase: NA
-
Tranexamic Acid Pharmacokinetics During Postpartum Hemorrhage
NCT03863964 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Evaluation of the Minimum Concentration of Tranexamic Acid Required to Inhibit Fibrinolysis in a Population of Pregnant Women at Term.
NCT02579941 ·Status: COMPLETED ·Phase: NA
-
Clinical Study to Assess the Equivalence of Tranexamic Acid vs Oxytocin in Reducing the PPH (TRANOXY2015)
NCT02503319 ·Status: WITHDRAWN ·Phase: PHASE3
-
Evaluating the Use of Tranexamic Acid (TXA) in Total Joint Arthroplasty
NCT03825939 ·Status: TERMINATED ·Phase: PHASE4
-
Tranexamic Acid to Reduce Blood Loss in Hemorrhagic Caesarean Delivery
NCT02797119 ·Status: COMPLETED ·Phase: PHASE4
-
A Prospective Evaluation of Thromboelastography for Identifying Coagulopathy in Severely Injured Patients
NCT01228058 ·Status: COMPLETED
-
Tranexamic Acid Use and Blood Loss in Total Hip Arthroplasty
NCT02989155 ·Status: COMPLETED
-
Efficacy of Topical Versus Intravenous Tranexamic Acid in Controlling Blood Loss
NCT06188052 ·Status: RECRUITING ·Phase: PHASE4
-
Efficacy Study of a TXA127 to Reduce Acute Graft-vs-Host Disease in Subjects Undergoing Double Umbilical Cord Blood Transplantation
NCT01882374 ·Status: WITHDRAWN ·Phase: PHASE2
-
Tranexamic Acid in Total Hip Arthroplasty.
NCT02252497 ·Status: COMPLETED ·Phase: PHASE4
-
Prevention of Postpartum Hemorrhage With Tranexamic Acid
NCT03287336 ·Status: COMPLETED ·Phase: PHASE2